PharmaCyte Going Head to Head with Eli Lilly's Pancreatic Cancer Drug in New Clinical Trial
January 24, 2017 09:10 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - January 24, 2017) - Ten years ago the National Cancer Institute (NCI) recognized the rise in pancreatic cancer deaths and called for the development of better treatments....
PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial
December 12, 2016 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - December 12, 2016) - All of the pieces are starting to fall into place for PharmaCyte Biotech (OTCQB: PMCB) and its upcoming human clinical trial in advanced pancreatic...
PharmaCyte Biotech Moves Closer to Enrolling Patients in Pancreatic Cancer Clinical Trial
December 01, 2016 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - December 01, 2016) - PharmaCyte Biotech (OTCQB: PMCB) is now one step closer to enrolling patients in a pivotal clinic trial in advanced, inoperable pancreatic cancer...
PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial
November 16, 2016 09:15 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - November 16, 2016) - PharmaCyte Biotech (OTCQB: PMCB) has arrived at the door of U.S. FDA and awaits a pre-IND meeting with the agency. After years of surrounding its...
PharmaCyte Biotech Clears Major Milestone on Path to FDA Clinical Trial
May 05, 2016 09:15 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - May 05, 2016) -  PharmaCyte Biotech (OTCQB: PMCB) has now reached a point in its life cycle where it is ready to start working with the U.S. FDA to get the company's...
PharmaCyte Biotech Moves Closer to Revealing Plan to Address Unmet Medical Need in Phase 2b Clinical Trial
September 30, 2015 09:30 ET | PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - September 30, 2015) - Cancer is the world's second most common cause of death, not too far behind heart disease. And, although no form of cancer is "good," pancreatic cancer...
PharmaCyte Biotech Has Only Scratched the Surface With Its Cell-in-a-Box(R) Technology
August 17, 2015 09:00 ET | PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - August 17, 2015) - PharmaCyte Biotech Inc. (OTCQB: PMCB) has made a name for itself with the company’s potentially game-changing pancreatic cancer treatment, and also as the...
PharmaCyte Biotech's Improved Technology Attracting World Class Oncologists
July 30, 2015 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - July 30, 2015) - PharmaCyte Biotech (OTCQB: PMCB) is a small international biotechnology firm, but you wouldn't know it by the company it keeps. How does PharmaCyte keep...
PharmaCyte Biotech Adds Cancer Drug All-Star to Its Scientific Advisory Board
July 21, 2015 09:00 ET | PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - July 21, 2015) - In the world of pharmaceuticals, the approval of a new drug is largely a matter of its relative performance rather than an absolute performance. That is,...